Evidence map›Paper›PMID 39771596›Full record

ArticlePharmaceutics2024

Potential of Cricket Chitosan for Nanoparticle Development Through Ionotropic Gelation: Novel Source for Cosmeceutical Delivery Systems.

Jirasit Inthorn, Pratthana Chomchalao, Puracheth Rithchumpon, Saranya Juntrapirom, Watchara Kanjanakawinkul, Thomas Rades, Wantida Chaiyana

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Biological activities and safety assessment ofInternational journal of pharmaceutics: X · 2026
    Article
  2. Enhanced encapsulation and membrane retention ofInternational journal of pharmaceutics: X · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jirasit InthornDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Pratthana ChomchalaoCollege of Medicine and Public Health, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.ORCID 0000-0002-3627-1086
Puracheth RithchumponDepartment of Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Saranya JuntrapiromChulabhorn Royal Pharmaceutical Manufacturing Facilities by Chulabhorn Royal Academy, Chon Buri 20180, Thailand.ORCID 0000-0002-3753-9005
Watchara KanjanakawinkulChulabhorn Royal Pharmaceutical Manufacturing Facilities by Chulabhorn Royal Academy, Chon Buri 20180, Thailand.
Thomas RadesDepartment of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.ORCID 0000-0002-7521-6020
Wantida ChaiyanaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-2868-7049

Funding

Center of Excellence in Pharmaceutical Nanotechnology, Faculty of Pharmacy, Chiang Mai UniversityChiang Mai UniversityMinistry of Higher Education, Science, Research, and Innovation, ThailandNational Research Council of Thailand N24A660305
6 · The paper itself

Abstract

BACKGROUND/

objectivesCrickets are recognized as an alternative source of chitosan. This study aimed to assess the potential of cricket-derived chitosan as a natural source to develop chitosan nanoparticles (CNPs).

methodsChitosan were isolated from different cricket species, including

resultsThe findings of this study indicate that chitosan can be successfully isolated from the three cricket species, with yields ranging from 4.35% to 5.22%

conclusionsCricket-derived chitosan compares favorably with crustacean-derived chitosan and showed potential for a range of applications, including the use as a nanocosmeceutical delivery system in topical and cosmetic formulations.

Indexed as

Acheta domesticuschitosancricketGryllus bimaculatusionotropic gelationnanoparticleTeleogryllus mitratus

Identifiers

PMID39771596
PMCPMC11676632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.